Search results
Results from the WOW.Com Content Network
A study published in the Journal of the American Medical Association in 2022 found a 60% reduction in moderate to severe depression and a 73% reduction in suicidality in trans and nonbinary youth prescribed puberty blockers. [8] A multi-year study published in September 2024 found that restrictions to transgender care, including restriction on ...
The quality of studies on puberty blockers and gender-affirming hormone therapy in adolescents. The report states that the existing evidence for both endocrine (puberty blockers and hormone therapy) and non-endocrine treatments (psychosocial interventions) in children and adolescents with gender incongruence is weak. [i]
Other peer-reviewed studies in the U.S. have found that puberty blockers are associated with positive mental health outcomes in transgender youth, including reduced depression, anxiety and ...
While puberty blockers pause puberty, gender-affirming hormones for older teens and adults help them hormonally mature into the bodily features associated with their gender identity — such as ...
Breen’s suit claims Olson-Kennedy’s clinic put her on puberty blockers when she was just 12, started her on hormone therapy at 13 and performed a double mastectomy on her at 14.
Puberty blockers give patients more time to solidify their gender identity before starting puberty. [24] While few studies have examined the effects of puberty blockers for transgender and gender non-conforming adolescents, the studies that have been conducted generally indicate that these treatments are reasonably safe and can improve ...
It found that less than 0.1% of U.S. transgender and gender diverse (TGD) adolescents were prescribed puberty blockers or gender-affirming hormones—and that not a single patient under age 12 ...
Bell v Tavistock was a case before the Court of Appeal (England and Wales) on the question of whether puberty blockers could be prescribed to under-16s with gender dysphoria. [1] The Court of Appeal said that "it was for clinicians rather than the court to decide on competence" to consent to receive puberty blockers. [2]